newsfilter
← Latest News
ACCESS Newswire·

Helix BioPharma Corp. Provides Third Bi-Weekly MCTO Status Update

RICHMOND HILL, ON / ACCESSWIRE / November 30, 2021 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, is providing this bi-weekly upda